Healthcare Triangle Executes Aggressive Growth Strategy, Announcing Within One Week Both $34 Million Planned Acquisition Revenue and Processing of $20 Million in Revenue Generated by Healthcare Providers on Ezovion Platform

Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream

PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc. (Nasdaq:HCTI), a leader in digital transformation solutions for the healthcare and life sciences industries, has announced two significant developments within the past few days that highlight the company's growing momentum in the AI-powered healthcare technology sector.

In an impressive one-week period, Healthcare Triangle has both signed a Letter of Intent to acquire Spain-based Teyame.AI in a transaction expected to generate approximately $34 million in incremental annual revenue, and announced that its wholly-owned subsidiary QuantumNexis has processed over $20 million in revenue generated by healthcare providers who rely on the Ezovion platform; and the consumption revenue with projections to reach $37 million within six months.

Taken together, these developments signal HCTI's strategic transformation from healthcare IT provider to comprehensive AI-driven digital health innovator with significant revenue scaling across multiple business lines.

Strategic Acquisition Creates Global Patient Engagement Platform

The Teyame.AI acquisition, announced on October 9, represents a pivotal step in HCTI's evolution. The transaction is expected to add approximately $34 million in incremental annual revenue and $4.2 million in incremental EBITDA while positioning the combined entity as a global force in AI-powered patient engagement.

Madrid-headquartered Teyame.AI has built a sophisticated platform that seamlessly blends artificial intelligence with human expertise, currently serving banking and insurance clients while piloting breakthrough healthcare applications.

The company's technology stack includes advanced chatbot automation, multilingual patient engagement tools, and real-time analytics, which are capabilities that become exponentially more powerful when integrated with HCTI's clinical systems.

The strategic acquisition addresses a critical gap in healthcare: the disconnect between advanced clinical systems and meaningful patient interaction.

By combining HCTI's deep healthcare technology expertise with Teyame's proven AI automation platform, the transaction creates an integrated ecosystem where every patient touchpoint becomes intelligent, personalized, and outcome-focused.